Growth Metrics

Cognex (CGNX) Cash & Equivalents (2016 - 2025)

Cognex's Cash & Equivalents history spans 17 years, with the latest figure at $262.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 41.29% year-over-year to $262.9 million, compared with a TTM value of $262.9 million through Dec 2025, up 41.29%, and an annual FY2025 reading of $262.9 million, up 41.29% over the prior year.
  • Cash & Equivalents for Q4 2025 was $262.9 million at Cognex, up from $245.9 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $395.5 million in Q4 2023, with the low at $524000.0 in Q3 2022.
  • Average Cash & Equivalents over 5 years is $188.7 million, with a median of $186.1 million recorded in 2021.
  • Year-over-year, Cash & Equivalents crashed 99.76% in 2022 and then surged 33771.18% in 2023.
  • Tracing CGNX's Cash & Equivalents over 5 years: stood at $186.2 million in 2021, then fell by 2.57% to $181.4 million in 2022, then grew by 11.73% to $202.7 million in 2023, then dropped by 8.17% to $186.1 million in 2024, then skyrocketed by 41.29% to $262.9 million in 2025.
  • Per Business Quant, the three most recent readings for CGNX's Cash & Equivalents are $262.9 million (Q4 2025), $245.9 million (Q3 2025), and $179.3 million (Q2 2025).